Legal Compliance Essentials for Drug, Device, and Biotech Companies
January 2-13, 2017
Online
2 J.D. Credits; 15 On-Demand CLE Credits; 15 Regulatory Affairs Certification Credits; 10.8 Compliance Certification Board Credits
Faculty: Dr. Seth Whitelaw, HLI Senior Fellow, Whitelaw Compliance Group, LLC

The U.S. health care system is composed of three primary parts: providers, payers, and finally manufacturers (drug, device, and biotech companies). It is a complex, complicated, and challenging system of laws, regulations, cases, guidance and, in some cases, folklore. This course is designed for the current and future attorney or compliance professional supporting drug, device, and biotech companies. Students will gain a practical understanding of the laws, regulations, cases, and guidance they will encounter in daily practice. Also, upon completion, all participants will understand how to design and operate an effective company compliance program.